Lauren Mayle, DO
Psychiatry · Morgantown, WVNPI 1205330909
Payments from drug & device makers
Across 25 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$154
- Otsuka America Pharmaceutical, Inc.$87
- Neurocrine Biosciences, Inc.$73
- Takeda Pharmaceuticals U.S.A., Inc.$50
- Vanda Pharmaceuticals Inc.$25
- Lilly USA, LLC$21
- plus $67 from 4 others
What the payments were for
- Food & beverage$477100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 7 | $154 |
| Otsuka America Pharmaceutical, Inc. | 5 | $87 |
| Neurocrine Biosciences, Inc. | 4 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Neos Therapeutics, LP | 1 | $18 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
How this compares
$477 in reported general payments places this provider in the 60th percentile of 177 psychiatry providers in West Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Venlafaxine Hcl ErVenlafaxine Hcl | 46 | $755 |
| Bupropion XlBupropion Hcl | 32 | $496 |
| Aripiprazole | 31 | $435 |
| Duloxetine Hcl | 40 | $377 |
| Buspirone Hcl | 39 | $349 |
| Risperidone | 17 | $312 |
| Fluoxetine Hcl | 43 | $200 |
| Sertraline Hcl | 27 | $198 |
| Escitalopram Oxalate | 33 | $166 |
| Trazodone Hcl | 24 | $94 |
| Quetiapine Fumarate | 19 | $88 |
| Clonazepam | 17 | $85 |
| Zolpidem Tartrate | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Morgantown
- Walter ByrdMorgantown$299K
- Francis YslaMorgantown$7K
- Melissa AlbertMorgantown$4K
- Wanhong ZhengMorgantown$3K
- John VaninMorgantown$1K
- Melissa MoodyCharleston$1.2M
- April BaisdenScott Depot$775K
- Ryan WakimWheeling$772K
- Daniel ThistlethwaiteSouth Charleston$468K
- Fahd MousaCharleston$200K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.